Literature DB >> 19685347

Hemolytic uremic syndrome (HUS)--incidence and etiologies at a regional Children's Hospital in 2001-2006.

R J Pomajzl1, M Varman, A Holst, A Chen.   

Abstract

Hemolytic uremic syndrome (HUS) is a serious health concern in children. HUS has primarily been linked to Escherichia coli O157:H7 infections, but non-O157 strains are gaining attention. Hemolytic anemia, thrombocytopenia, and acute renal failure are the characteristics of the syndrome. This study investigated the incidence of HUS at a regional Children's Hospital between 2001 and 2006 by retrospective review. Cases of HUS were investigated for outcomes based on stool culture and an association of acute pancreatitis. A total of 44 cases were identified, of which 57% were female and 43% were male, with an age distribution of 13 months to 17 years and a median age of 3.44 years. Data revealed 13 cases in 2006 compared to two cases in 2001, with 84% of all illnesses occurring in the summer and fall seasons. The median duration of thrombocytopenia was eight days and 50% of all cases required dialysis. E. coli O157:H7 was the predominant pathogen; however, 53% of the cases had unknown etiology. This data may suggest a growing number of cases from 2001 to 2006 and a role for agents other than E. coli O157:H7. E. coli O157:H7 caused longer intensive care unit (ICU) stay. No association between HUS and acute pancreatitis was found.

Entities:  

Mesh:

Year:  2009        PMID: 19685347     DOI: 10.1007/s10096-009-0800-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome.

Authors:  David A Sass; Kapil B Chopra; Miguel D Regueiro
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

2.  Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.

Authors:  Mark E Wickham; Claudia Lupp; Mariola Mascarenhas; Alejandra Vazquez; Brian K Coombes; Nat F Brown; Bryan A Coburn; Wanyin Deng; Jose L Puente; Mohamed A Karmali; B Brett Finlay
Journal:  J Infect Dis       Date:  2006-08-11       Impact factor: 5.226

3.  Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection?

Authors:  Manohara Joishy; Praveen Jauhari; Ann A Mathew; T Rangarajan
Journal:  Arch Dis Child       Date:  2008-02       Impact factor: 3.791

4.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

5.  Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection.

Authors:  M C Hogan; J M Gloor; J R Uhl; F R Cockerill; D S Milliner
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

Review 6.  Hemolytic uremic syndrome: an emerging health risk.

Authors:  Samiya Razzaq
Journal:  Am Fam Physician       Date:  2006-09-15       Impact factor: 3.292

7.  Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis.

Authors:  S Grodinsky; A Telmesani; W L Robson; G Fick; R B Scott
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-11       Impact factor: 2.839

8.  Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska.

Authors:  P D Fey; R S Wickert; M E Rupp; T J Safranek; S H Hinrichs
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

9.  Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience.

Authors:  Aoife M Waters; Larissa Kerecuk; David Luk; Mushfequr R Haq; Margaret M Fitzpatrick; Rodney D Gilbert; Carol Inward; Caroline Jones; Bruno Pichon; Christopher Reid; Mary P E Slack; William Van't Hoff; Michael J Dillon; C M Taylor; Kjell Tullus
Journal:  J Pediatr       Date:  2007-08       Impact factor: 4.406

10.  Interactions of Shiga-like toxin with human peripheral blood monocytes.

Authors:  Joyce M Geelen; Thea J A M van der Velden; Lambertus P W J van den Heuvel; Leo A H Monnens
Journal:  Pediatr Nephrol       Date:  2007-05-22       Impact factor: 3.714

View more
  4 in total

1.  Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.

Authors:  Marie-Agnès Dragon-Durey; Sidharth Kumar Sethi; Arvind Bagga; Caroline Blanc; Jacques Blouin; Bruno Ranchin; Jean-Luc André; Nobuaki Takagi; Hae Il Cheong; Pankaj Hari; Moglie Le Quintrec; Patrick Niaudet; Chantal Loirat; Wolf Herman Fridman; Véronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

Review 2.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

3.  Point-of-care multiplex-PCR enables germ identification in haemolytic uremic syndrome 94 h earlier than stool culture.

Authors:  Luis Hernán Llano López; Pablo Melonari; Stephan Gehring; Daniel Schreiner; Sandra Grucci; Sofía Pérez Araujo; Lorena Di Pauli; Christina Oetzmann von Sochaczewski; Arne Schröder; Laura Piovano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-04       Impact factor: 3.267

4.  Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007.

Authors:  Kanyin L Ong; Mirasol Apostal; Nicole Comstock; Sharon Hurd; Tameka Hayes Webb; Stephanie Mickelson; Joni Scheftel; Glenda Smith; Beletshachew Shiferaw; Effie Boothe; L Hannah Gould
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.